Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances - Page 3 of 6 - The Rheumatologist
Upadacitinib doubles ASAS 40 response vs. placebo in ankylosing spondylitis | MDedge Rheumatology
Upadacitinib improves signs, symptoms in patients with active AS
offer van der Heijde (@VanOffer) / Twitter
Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances - The Rheumatologist
Biography Roel van der Heijde - Roel Rotterdam
Ward van der Heijde | Flickr
Researcher comment: The SELECT-AXIS 1 trial | Désirée van der Heijde - YouTube
Uncertainty common for those treating patients with non-radiographic axial spondyloarthritis - ACR Convergence Today
Van Der Heijde
Chris van der Heijde van De Hypotheekshop Hoogvliet
Bram van der Heijde - Senior Toezichthouder Warmtenetten - Senior Advisor District Heating Regulation - VREG - Vlaamse Regulator van de Elektriciteits- en Gasmarkt | LinkedIn
Amber van der Heijde - Wikipedia
Kelly van der Heijde - Verdonck, Klooster & Associates
Desiree M. Van Der Heijde | MediFind
Peter van der Heijde official Wim Hof Method Instructor
Claudia VAN DER HEIJDE | Senior Researcher | PhD | University of Amsterdam, Amsterdam | UVA | Department of Research, Development and Prevention, Student Health Service | Research profile